Cargando…

Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence

Without preventive interventions, women with germline pathogenic variants in BRCA1 or BRCA2 have high lifetime risks for breast cancer and tubo-ovarian cancer. The increased risk for breast cancer starts at a considerably younger age than that for tubo-ovarian cancer. Risk-reducing bilateral salping...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conduit, Ciara, Milne, Roger L., Friedlander, Michael L., Phillips, Kelly-Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662899/ https://www.ncbi.nlm.nih.gov/pubmed/34348913 http://dx.doi.org/10.1158/1940-6207.CAPR-21-0141

Ejemplares similares

Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation
por: Kotsopoulos, Joanne, et al.
Publicado: (2019)

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
por: Menkiszak, Janusz, et al.
Publicado: (2016)

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
por: Lee, Young-Jae, et al.
Publicado: (2017)

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
por: Rebbeck, Timothy R., et al.
Publicado: (2009)

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
por: Metcalfe, Kelly A, et al.
Publicado: (2005)

Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series
por: Barker, Victoria E., et al.
Publicado: (2023)

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
por: Jung, Sung Mi, et al.
Publicado: (2020)

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
por: Menkiszak, Janusz, et al.
Publicado: (2019)

A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients
por: Loizzi, Vera, et al.
Publicado: (2022)

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
por: Marchetti, Claudia, et al.
Publicado: (2014)

Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm
por: Gasparri, Maria Luisa, et al.
Publicado: (2019)

The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in BRCA Mutation Carriers and the Role of Physician-Patient Communication
por: Alves-Nogueira, Ana C., et al.
Publicado: (2023)

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women
por: Sidon, L, et al.
Publicado: (2012)

Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan
por: Konnai, Katsuyuki, et al.
Publicado: (2023)

BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
por: Sekine, Masayuki, et al.
Publicado: (2021)

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
por: Gaba, Faiza, et al.
Publicado: (2022)

Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
por: Gaba, Faiza, et al.
Publicado: (2023)

The Effect of Risk-Reducing Salpingo-Oophorectomy on Breast Cancer Incidence and Histopathological Features in Women with a BRCA1 or BRCA2 Germline Pathogenic Variant
por: Stuursma, Annechien, et al.
Publicado: (2023)

Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female Germline BRCA1/2 Mutation Carriers: A Retrospective Cohort Study
por: Lim, Hyunji, et al.
Publicado: (2021)

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up
por: Olivier, R I, et al.
Publicado: (2004)

Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers
por: Wu, Shandong, et al.
Publicado: (2015)

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors
por: Stroot, Iris A.S., et al.
Publicado: (2023)

Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review
por: Nitschke, Amanda S., et al.
Publicado: (2023)

Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan
por: Nomura, Hidetaka, et al.
Publicado: (2023)

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
por: Harmsen, Marline G., et al.
Publicado: (2015)

Risk-Reducing Salpingo-Oophorectomy (RRSO) Combined with Simultaneous Mastectomy in Women with BRCA 1–2 Mutation Carriers: The Surgical Technique, the Feasibility and Patients’ Satisfaction of Multiple Surgeries
por: Saccardi, Carlo, et al.
Publicado: (2022)

Erratum to: Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers
por: Wu, Shandong, et al.
Publicado: (2015)

An explainable machine learning ensemble model to predict the risk of ovarian cancer in BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
por: Comes, Maria Colomba, et al.
Publicado: (2023)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019)

Bilateral Salpingo-Oophorectomy for Intracardiac Leiomyomatosis: A Case Report
por: Liang, Jinxiao, et al.
Publicado: (2022)

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy
por: Sekine, Masayuki, et al.
Publicado: (2022)

Theory‐based behavior change intervention to increase uptake of risk‐reducing salpingo‐oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial
por: Metcalfe, Kelly A., et al.
Publicado: (2023)

Laparoscopic Salpingo-oophorectomy in Conscious Sedation
por: Rosati, Maurizio, et al.
Publicado: (2015)

The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation
por: Monterossi, G, et al.
Publicado: (2022)

Penetrance of Breast and Ovarian Cancer in Women Who Carry a BRCA1/2 Mutation and Do Not Use Risk-Reducing Salpingo-Oophorectomy: An Updated Meta-Analysis
por: Chen, Jinbo, et al.
Publicado: (2020)

The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers
por: Grossman, Sharon Galper
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r8629mr6qfbgjob7e72sk8msjj